biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
Category
Uncategorized
31
Mar
Prof. Piotr Garstecki on the cover of Forbes magazine!
31.03.2023
SCOPE FLUIDICS
Uncategorized
Read More
31
Mar
Scope Fluidics in the top class of the capital market according to the Stock Exchange and Investors Gazette “Parkiet”
31.03.2023
SCOPE FLUIDICS
Uncategorized
Read More
15
Mar
Scope Fluidics publishes Development Strategy
15.03.2023
SCOPE FLUIDICS
Uncategorized
Read More
08
Mar
What happens if we run out of antibiotics? Prof. Piotr Garstecki at Cordis European Commision portal
08.03.2023
SCOPE FLUIDICS
Uncategorized
Read More
08
Mar
BacterOMIC achieves Patent for Microfluidic Chip in Chinese Market
08.03.2023
SCOPE FLUIDICS
Uncategorized
Read More
21
Feb
Scope Fluidics’ Management Board recommends payment of PLN 85.57 per share in the form of a dividend, which implies a dividend yield of approximately 30%
21.02.2023
SCOPE FLUIDICS
Uncategorized
Read More
20
Jan
Scope Fluidics debuted on the Main Market at Warsaw Stock Exchange
20.01.2023
SCOPE FLUIDICS
Uncategorized
Read More
18
Jan
Scope Fluidics S.A. moves to the Warsaw Stock Exchange (WSE) main market
18.01.2023
SCOPE FLUIDICS
Uncategorized
Read More
30
Jun
Scope Fluidics starts distribution of PCR|ONE system
30.06.2022
SCOPE FLUIDICS
Uncategorized
Read More
04
Aug
Bio-Rad Acquires Curiosity Diagnostics
04.08.2022
SCOPE FLUIDICS
Uncategorized
Read More
1
…
4
5
6
7
8
…
14
Search
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments
Tag Cloud
home
Recent Comments